-
Redhill Trial for Migraine
May 16, 2012 |Comments are closed -
CollPlant Wound Trial Interim Results
May 10, 2012 |Comments are closed -
BrainStorm to do MS Stem Cell Study
May 10, 2012 |Comments are closed -
Rosetta Genomics Gets Cancer Diagnostic Patent
May 10, 2012 |Comments are closed -
Brainsway: Positive Depression Trial Results
May 10, 2012 |Comments are closed -
InspireMD Completing Stent Trial
May 10, 2012 |Comments are closed -
Protalix Gets FDA Approval
May 10, 2012 |Comments are closed -
D-Pharm Gets $1M from Chinese Partner
May 10, 2012 |Comments are closed -
cCam Raises $3 M
May 9, 2012 |Comments are closed -
Pluristem Phase II Uses Placenta-Based Therapy
April 29, 2012 |Comments are closed -
BioLert Links with My Epilepsy Diary
April 28, 2012 |Comments are closed -
Prolor: Positive Obesity/Diabetes Study
April 27, 2012 |Comments are closed -
Can-Fite: Ophthalix Drug Effective for Eye Disease
April 27, 2012 |Comments are closed -
Foamix Topical Foam Patented
April 26, 2012 |Comments are closed -
BioPharma Equipment Pages Launched
April 16, 2012 |Comments are closed -
Canine VacciCheck Reaches U.S. Market
April 9, 2012 |Comments are closed -
Tiltan Phase II Pancreatic Cancer
February 26, 2012 |Comments are closed -
Tech Tour Seeks Promising Israeli Medtechs
February 26, 2012 |Comments are closed -
Sol-Gel Raises $27 M
February 2, 2012 |Comments are closed -
Neurology Journal: BrainStorm Stem Cells May Help Huntington’s
February 1, 2012 |Comments are closed
-
IDEA Launches Push-of-a-Button Cell Imaging System
IDEA Bio-Medical Ltd. (IDEA Bio) and The Medical University of South Carolina (MUSC) announced last month that they have completed...
Dial 15.9 Herz For Blood Flow
Aerotel has started a clinical trial for heart patients at the Sheba Medical Center using a technology that is not...
450 Meetings at BioInvest
Business people from 20 countries attended the first BioInvest conference held in Haifa at the beginning of March. According to...
Tiltan Combo for Cancer
The number four is of special significance to Tiltan Pharma a developer of anti-angiogenetic cancer drugs. The company’s core technology...
Procognia: Glyco-Protein Diagnostics and Drugs
A blood test that can determine if a person has a cancer disease continues to be one of the most...
Sol-Gel Signs $27 M Deal
Sol-Gel Technologies Ltd. announced that it has entered into a second development and licensing agreement with a leading U.S. pharmaceutical...
Genetics in Parkinson’s at TAU
Since its inception in 2000, The Michael J. Fox Foundation (MJFF) has funded $6.5 million in Parkinson’s disease (PD) research...
cCam: A Personalized MAb for Melanoma
Yervoy, the first FDA approved drug for metastatic melanoma, hit the market during the past year with first quarter sales...
Healthcare Marketing in Arab World
Healthcare companies targeting the Arab world may be surprised to discover that the best point of entry may be through...
U.S. Funding for Aging-Related Technology
Israeli researchers working on technology that contributes to public health, especially to that of the elderly population, can receive assistance...
Here Come the NanoMAbs
A new monoclonal antibody-based drug development company brings a fresh technological approach and ambitious business model to the Israeli biotech...
82 Cardio-Vascular Co’s And Growing
Israel leads the world in the number of cardio-vascular medical device companies, said Prof. Rafael Beyar in a presentation at...
BIRAX Launches £10 million UK-Israel Research Program
Support for 15 UK-Israel research projects was announced at the first UK-Israel Regenerative Medicine Conference at Ben-Gurion University of the...
Petitioners Fight Merging Biomed With Hi Tech
More than 250 members of Israel’s life sciences industry have signed a petition opposing the proposed merger of the Israeli...
Daniel Chain: $126 M Deal
While heading the Israeli company, Mindset BioPharmaceuticals, Dr. Daniel Chain developed a drug compound known as OX1. The drug has now resulted...
Iris Geffen Gloor: UK Hub Biomed Manager
Increasing collaborations between Israeli and UK biomed companies is the goal of the new High-Tech Hub recently launched in Tel...
Polyrizon at BIO-Europe: Polymer Allergy Gel
Technology to protect mucosal membranes from pathogens such as pollen, viruses and bacterium was presented at this year’s Bio-Europe conference...
Eran Gilat: Research Aesthetics
Photos by a researcher from the Israel Institute for Biological Research have drawn large crowds at exhibits in New York,...
